Table 2.

Number of new vessels on histopathologic evaluation of corneal sections in each group (mean ± standard deviation)

Study Group†	Number of new vessels*
Controls (n = 10)	18.8 ± 5.8
Group 1 (n = 12)	11.4 ± 3.7
Group 2 (n = 11)	10.5 ± 4.3
Group 3 (n = 11)	8.8 ± 3.6

^*Mean number of new vessels was significantly higher in the control group as compared to groups 1, 2 and 3 (P=0.007, 0.003 and <0.001, respectively).

^†Group 1, bevacizumab-treated eyes; Group 2, triamcinolone treated and triamcinolone